Cystic fibrosis and smoking: a hidden problem?

NCT ID NCT07342920

Recruiting now Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is surveying 100 adults with cystic fibrosis to find out how many smoke or vape. Many people assume that patients with cystic fibrosis don't smoke, but there is almost no data on this. The results will help doctors improve tobacco prevention and understand how smoking or vaping might interact with the drug Kaftrio.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide crucial data to tailor smoking prevention programs for people with cystic fibrosis and help doctors understand how smoking or vaping might affect Kaftrio treatment.
What could go wrong: This is an observational study with only 100 participants from one center, so results may not apply to all people with cystic fibrosis. It does not test any new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis Smoking Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYSTIC FIBROSIS

Contacts and locations

Locations

Service de Pneumologie - CHU de Strasbourg - France
RECRUITING

Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.